Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas

Journal of Clinical Oncology

Volumn 25, Issue 22, 2007, Pages 3321-3329

  Cuadros, Marta ^a   Dave, Sandeep S ^a   Jaffe, Elaine S ^a   Honrado, Emiliano ^a   Milne, Roger ^a   Alves, Javier ^a   Rodríguez, Jose ^a   Zajac, Magdalena ^a   Benitez, Javier ^a   Staudt, Louis M ^a   Martinez Delgado, Beatriz ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A2; CYCLIN B2; CYCLINE; DNA TOPOISOMERASE (ATP HYDROLYSING); UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER SURVIVAL; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NODAL PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; T CELL LYMPHOMA; TUMOR BIOPSY;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHOMA, T-CELL; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 34548254943     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.09.4474     Document Type: Article

References (44)

1. Jaffe ES, Harris NL, Stein H, et al: World Health Organisation Classification of Tumors: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France, IARC Press, 2001
2. Suchi T, Lennert K, Tu LY, et al: Histopathology and immunohistochemistry of peripheral T cell lymphomas: A proposal for their classification. J Clin Pathol 40:995-1015, 1987
3. Gisselbrecht C, Gaulard P, Lepage E, et al: Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas: Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood 92:76-82, 1998
4. Poulsen CB, Borup R, Nielsen FC, et al: Microarray-based classification of diffuse large B-cell lymphoma. Eur J Haematol 74:453-465, 2005
5. Rosenwald A, Wright G, Chan WC, et al: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346:1937-1947, 2002
6. Shipp MA, Ross KN, Tamayo P, et al: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 8:68-74, 2002
7. Alizadeh AA, Eisen MB, Davis RE, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511, 2000
8. Haferlach T, Kohlmann A, Schnittger S, et al: Global approach to the diagnosis of leukemia using gene expression profiling. Blood 106:1189-1198, 2005
9. Fernando AA, Look AT: Gene expression profiling in T-cell acute lymphoblastic leukemia. Semin Hematol 40:274-280, 2003
10. Piccaluga PP, Agostinelli C, Zinzani PL, et al: Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified. Lancet Oncol 6:440, 2005
11. Martínez-Delgado B, Cuadros M, Honrado E, et al: Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas. Leukemia 19:2254-2263, 2005
12. Ballester B, Ramuz O, Gisselbrecht C, et al: Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas. Oncogene 25:1560-1570, 2006
13. de Leval L, Rickman DS, Thielen C, et al: The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AILT) and follicular helper T cells (TFH). Blood [epub ahead of print on February 6, 2007]
14. Ansell SM, Habermann TM, Kurtin PJ, et al: Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. J Clin Oncol 15:2296-2301, 1997
15. Escalón MP, Liu NS, Yang Y, et al: Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: The M.D. Anderson Cancer Center experience. Cancer 103:2091-2098, 2005
16. Gallamini A, Stelitano C, Calvi R, et al: Peripheral T-cell lymphoma unspecified (PTCL-U): A new prognostic model from a retrospective multicentric clinical study. Blood 103:2474-2479, 2004
17. Coiffier B, Brousse N, Peuchmaur M, et al: Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: A prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen - The GELA (Groupe d'Etude des Lymphomes Agressives). Ann Oncol 1:45-50, 1990
18. Lardelli P, Bookman MA, Sundeen J, et al: Lymphocytic lymphoma of intermediate differentiation: Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 14:752-763, 1990
19. Räty R, Franssila K, Joensuu H, et al: Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma. Eur J Haematol 69:11-20, 2002
20. Alexandrakis MG, Passam FH, Kyriakou DS, et al: Expression of the proliferation-associated nuclear protein MIB-1 and its relationship with microvascular density in bone marrow biopsies of patients with myelodysplastic syndromes. J Mol Histol 35:857-863, 2004
21. Katzenberger T, Petzoldt C, Holler S, et al: The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma. Blood 107:3407, 2006
22. Martinez-Delgado B, Melendez B, Cuadros M, et al: Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes. Clin Cancer Res 10:4971-4982, 2004
23. Renedo M, Martinez-Delgado B, Arranz E, et al: Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas. Leukemia 15:1627-1632, 2001
24. Spanish National Cancer Centre: Functional classification of the contents of the human CNIO cDNA microarray (OncoChip) v2. http://www.cnio.es/UserFiles/ File/Biotecnologia/Genomica/ochip_v2.xls
25. Spanish National Cancer Centre: Bioinformatics Unit-CNIO: DNMAD. http://dnmad.bioinfo.cnio.es/
26. Yang YH, Dudoit S, Luu P, et al: Normalization for cDNA microarray data: A robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30:e15, 2002
27. Spanish National Cancer Centre: Bioinfomratics CNIO. http:// bioinformatica.cnio.es/
28. European Bioinformatics Institute: ArrayExpress. http://www.ebi.ac.uk/ arrayexpress/
29. Dave SS, Fu K, Wright GW, et al: Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 354:2431-2442, 2006
30. Went P, Agostinelli C, Gallamini A, et al: Marker expression in peripheral T-cell lymphoma: A proposed clinical-pathologic prognostic score. J Clin Oncol 24:2472-2479, 2006
31. Tracey L, Villuendas R, Ortiz P, et al: Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Am J Pathol 161:1825-1837, 2002
32. Tracey L, Villuendas R, Dotor AM, et al: Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: An expression profile study. Blood 102:1042-1050, 2003
33. Hastrup N, Ralfkiaer E, Pallesen G: Aberrant phenotypes in peripheral T cell lymphomas. J Clin Pathol 42:398-402, 1989
34. Pinkus GS, O'Hara CJ, Said JW: Peripheral/post-thymic T-cell lymphomas: A spectrum of disease - Clinical, pathologic, and immunologic features of 78 cases. Cancer 65:971-998, 1990
35. Reiser M, Josting A, Soltani M, et al: T-cell non-Hodgkin's lymphoma in adults: Clinicopathological characteristics, response to treatment and prognostic factors. Leuk Lymphoma 43:805-811, 2002
36. Rüdiger T, Weisenburger DD, Anderson JR, et al: Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): Results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 13:140-149, 2002
37. Sonnen R, Schmidt WP, Muller-Hermelink HK, et al: The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas. Br J Haematol 129:366-372, 2005
38. Drobnjak M, Latres E, Pollack D, et al: Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J Natl Cancer Inst 86:549-554, 1994
39. Raymond WA, Leong AS, Bolt JW, et al: Growth fractions in human prostatic carcinoma determined by Ki-67 immunostaining. J Pathol 156:161-167, 1988
40. Kerns BJ, Jordan PA, Faerman LL, et al: Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis. Am J Clin Pathol 101:192-197, 1994
41. Pence JC, Kerns BJ, Dodge RK, et al: Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer. Arch Surg 128:1382-1390, 1993
42. Rosenwald A, Wright G, Wiestner A, et al: The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3:185-197, 2003
43. Mihaljević B, Nedeljkov-Jancic R, Cemerikic-Martinovic V, et al: Ki-67 proliferative marker in lymph node aspirates of patients with non-Hodgkin's lymphoma. Med Oncol 23:83-89, 2006
44. Pfreundschuh M, Trumper L, Kloess M, et al: Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: Results of the NHL-B2 trial of the DSHNHL. Blood 104:634-641, 2004